The Native Antigen Company continues to expand its portfolio to support critical needs across autoimmune and infectious disease testing. Our newest FY26 releases are engineered for strong lot‑to‑lot reproducibility, well‑defined characteristics, and dependable global availability.
We’re excited to share several newly launched recombinant products designed to help diagnostic developers enhance assay accuracy, consistency, and long‑term supply reliability.
New & Featured Recombinant Products
- RF (Rheumatoid Factors) – NEW
J‑chain–stabilized recombinant human IgM RF for native‑like reactivity and consistent performance across diagnostic platforms.
- Recombinant Human Hormones
FSH, SHBG, TSH, Prolactin, hCGβ – High‑quality human proteins produced for reliable, scalable use in IVD assay development.
- TORCH Antigens & Antibodies
CMV, HSV, Toxoplasma – Mammalian‑expressed antigens and antibodies with accurate folding, strong specificity, and dependable serology assay performance.
- Recombinant Influenza HA/NA Antigens
Mammalian‑expressed HA and NA antigens with native‑like structure to support immunoassay development and influenza research.
Special Bulk‑Pricing Available
We’re pleased to offer new bulk‑pricing options across our Flaviviruses NS1 antigen range, including DENV1–4, YFV, WNV, JEV, TBEV, SLEV, POWV, USUV, and WESSV.
Our recombinant NS1 proteins are highly purified, correctly folded, and consistently high‑performing—ideal for serology assay development, surveillance programs, and vaccine research.
